First EVER Phase III Clinical Trial for FSGS Announced!

First EVER Phase III Clinical Trial for FSGS Announced TODAY!

Retrophin has announced that their Phase III trial for Sparsentan has launched today. This trial is critical for getting new and better treatments to FSGS patients.

To learn more about clinical trials, contact Chelsey Fix at cfix@nephcure.org.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s